Central venous access port-related complications in outpatient chemotherapy for colorectal cancer

Japanese Journal of Clinical Oncology

Volumn 37, Issue 12, 2007, Pages 951-954

  Inaba, Yoshitaka ^a   Yamaura, Hidekazu ^a   Sato, Yozo ^a   Najima, Mina ^a   Shimamoto, Hiroshi ^a   Nishiofuku, Hideyuki ^a   Ura, Takashi ^a   Muro, Kei ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Central venous access port; Colorectal cancer; Complication; Outpatient home chemotherapy; Portable disposable pump

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINATE CALCIUM; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CATHETER COMPLICATION; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; COLORECTAL CANCER; CONTINUOUS INFUSION; DEVICE REMOVAL; HEMATOMA; HUMAN; IMPLANTABLE PORT SYSTEM; INFUSION PUMP; MAJOR CLINICAL STUDY; OUTPATIENT; OUTPATIENT CARE; PRURITUS; PUMP DESIGN; SAFETY; SKIN INJURY; SKIN IRRITATION;

ADULT; AGED; AMBULATORY CARE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CATHETERIZATION, CENTRAL VENOUS; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; INCIDENCE; JAPAN; LEUCOVORIN; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 38749151957     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym118     Document Type: Article

References (13)

1. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23-30.
2. Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 2004, 22:229-37.
3. Biffi R, de Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, et al. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 2001;92:1204-12.
4. Kuroiwa T, Honda H, Yoshimitsu K, Irie H, Aibe H, Shinozaki K, et al. The complications of Central Venous Port Access System. Jpn J Intervent Radiol 2002;17:39-43.
5. Bjarnason H, Lehmann S. Central venous access, In: Castaneda-Zuniga WR, editor. Interventional Radiology. Baltimore: Williams Wilkins 1997,941-65.
6. Hull JE, Hunter CS, Luiken GA. The Groshoug catheter: Initial experience and early results of imaging-guided placement. Radiology 1992;185:803-7.
7. Belin RP, Koster JK, Jr, Bryant LJ, Griffen WO, Jr. Implantable subcutaneous feeding chamber for noncontinuous central venous alimentation. Surg Gynecol Obstet 1972;134:491-3.
8. Torramade JR, Cienfuegos JA, Hernandez JL, Pardo F, Benito C, Gonzalez J, et al. The complications of central venous access systems: A study of 218 patients. Eur J Surg 1993; 159:323-7.
9. Mansfield PF, Hohn DC, Fornage BD, Gregurich MA, Ota DM. omplications and failures of subctavian-vein catheterization. N Engl J Med 1994;331:1735-8.
10. Openshaw KL, Picus D, Hicks ME, Darcy MD, Vesely TM, Picus J. Interventional radiologic placement of Hohn central venous catheters: results and complications in 100 consecutive patients. J Vasc Interv Radiol 1994;5:111-5.
11. Funaki B, Szymski GX, Hackworth CA, Rosenblum JD, Burke R, Chang T, et al. Radiologic placement of subcutaneous infusion chest ports for long-term central venous access. Am J Roentgenol 1997;169:1431-4.
12. Goossens GA, Vrebos M, Stas M, de, Wever I, Frederickx L. Central vascular access devices in oncology and hematology considered from a different point of view: How do patients experience their vascular access ports? J Infus Nurs 2005;28:61-7.
13. Ahlin C, Klang-Soderkvist B, Brundin S, Hellstrom B, Pettersson K, Johansson E. Implementation of a written protocol for management of central venous access devices: A theoretical and practical education, including bedside examinations. J Infus Nurs 2006;29:253-9.